Looking to publish in Clinical Infectious Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowClinical Infectious Diseases is an Infectious Diseases Society of America journal published by Oxford University Press.
Looking to publish in Clinical Infectious Diseases? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Try Livewrite NowSubmission Instructions
Clinical Infectious Diseases accepts the following article types. Click on an article type to view submission instructions.
Original Article
Review Article
Clinical Practice Guideline / Consensus Statement
Perspective
Case Report
Recent Publications
Safety and Tolerability of Oral Islatravir Once Monthly as Pre-Exposure Prophylaxis in Cisgender Men and Transgender Women Who Have an Elevated Likelihood of HIV-1 Exposure: Results From the IMPOWER-24 Randomized Phase 3 Study
Raphael J Landovitz, Yvett Pinedo, Federico Hinestrosa, Gordon E Crofoot, Cynthia Brinson, Susan Buchbinder, Jean-Michel Molina, Ronnie M Gravett, James B Brock, Moti N Ramgopal, A Lina Rosengren, Igho Ofotokun, Jose Valdez Madruga, Geoffroy Liegeon, Ravindre Panchia, Khuanchai Supparatpinyo, Anchalee Avihingsanon, Catherine Creticos, Shobha Swaminathan, Susanne Doblecki-Lewis, Jorge Rodriguez, Marc Siegel, Shinichi Oka, Thanyawee Puthanakit, Beatriz Grinsztejn, Eduard J Sanders, Javier R Lama, Johannes Lombaard, Nkosiphile Ndlovu, Peggy Hwang, Jiejun Du, Beth Jackson, Brenda Homony, Barbara Evans, Peter Sklar, Michael N Robertson, Rebeca M Plank
Cephalosporins Versus Non-Cephalosporin Antibiotics for Perioperative Prophylaxis in Primary Arthroplasty: A Systematic Review and Meta-Analysis
Rita Igwilo-Alaneme, Elie Berbari, Jack McHugh, Francesco Petri, Vasupriya Ravi, Takahiro Matsuo, Fabio Borgonovo, Said El Zein, M Hassan Murad, Aaron Tande
Patterns of HIV-1 viral load suppression and drug resistance during the dolutegravir transition: a population-based longitudinal study
Michael A Martin, Alexandra Blenkinsop, Michelle Moffa, Steven James Reynolds, Fred Nalugoda, Thomas C Quinn, Godfrey Kigozi, Robert Ssekubugu, Ravindra K Gupta, Nicholas E Grayson, George MacIntyre-Cockett, Joseph Kagaayi, Gertrude Nakigozi, Lucie Abeler-Dörner, Christophe Fraser, Oliver Ratmann, Aaron A R Tobian, Oliver Laeyendecker, Sikhulile Moyo, Caitlin E Kennedy, David Bonsall, Ronald Moses Galiwango, M Kate Grabowski
When are uncontrolled trials in TB scientifically and ethically justified: Borrowing wisdom from early AIDS clinical trials
Lindsay McKenna, Mike Frick, Valentina A Alarcón-Guizado, Geraint Davies, Jennifer J Furin, Lorenzo Guglielmetti, Norbert Heinrich, Marcus Low, Mariama Mahmoud, Vidya Mave, Norbert Ndjeka, Patrick P J Phillips, Samuel Schumacher, Mark Harrington, Carole D Mitnick
Estimating changes in facility MRSA infection rates due to changes in MRSA precaution policy
Karim Khader, Candace Haroldsen, Vanessa Stevens, Lindsay Visnovsky, Martin Evans, Loretta Simbartl, Brian McCauley, Matthew Samore, Michael Rubin
Frequently asked questions
How long does it take to publish?
Median days to first decision: 6 (with desk rejects) and 39 (without desk rejects). Median days to final decision: 8 (with desk rejects) and 72 (without desk rejects). Online publication occurs within 24–72 hours of acceptance; corrected proofs are published within 3–5 weeks.
Reformat to Clinical Infectious Diseases using Livewrite Premium